PO.PS01.11 · 人群科学

评估一项面向初级保健提供者的培训干预,以帮助患者为与肿瘤科医生讨论癌症做好准备

Evaluation of a training intervention for primary care providers to prepare patients for cancer discussions with their oncologists

编号 7573 展板 21 时间 4/22 09:00–12:00 区域 Section 34 主讲 Carma Bylund, BA;MA;PhD
分会场 Psychosocial and Behavioral Epidemiology, Health Services Research, Implementation Science, Pharmacoepidemiology, and Other Topics
该海报暂无可下载的资料 AACR 官方页面

作者与单位 Authors & Affiliations

Carma Bylund1, Alyssa Crowe1, Margo Michaels2, Domenic Durante1, Maria Sae-Hau3, Andrea Cassells4, Jason Arnold1, Ana Natale-Pereira5, Raymond Mailhot Vega6, Zhongyue Zhang1, Ji-Hyun Lee1, Elisa S. Weiss3

1University of Florida, Gainesville, FL,2Health Care Access & Action, Boston, MA,3Blood Cancer United, Rye Brook, NY,4Clinical Directors Network, New York, NY,5Rutgers New Jersey Medical School, Newark, NJ,6University of Florida, Jacksonville, FL

摘要 Abstract

中文摘要
我们考察了一项名为“帮助患者为癌症治疗讨论做准备”的在线培训干预对初级保健提供者的知识、态度/信念以及沟通/转诊行为的影响。 我们与临床主任网络(CDN)、佛罗里达家庭医师学会以及美国住院医师培训项目主任合作,招募初级保健提供者(MD、DO、NP和PA)、家庭医学住院医师、内科住院医师和老年医学专科培训医师。这项1小时的异步在线培训由三位教师主持:一名初级保健提供者、一名放射肿瘤科医生和一名癌症临床试验专家。参与者通过模拟患者和临床情景进行练习,以掌握有关肿瘤科转诊和癌症临床试验的沟通技巧。培训前和培训后的调查测量了知识、态度、信念以及讨论试验的意愿。此外,一项3个月随访调查测量了培训对临床试验转诊沟通行为的持续影响。 135名初级保健提供者(91名住院医师,44名执业临床医生)参加了本次培训干预(3个月随访时保留率为84%)。培训后知识水平立即从平均51.8%正确率提高至82.4%正确率(p < .001),并在3个月随访时得以维持,平均得分为77.7%正确率(p < .001)。关于初级保健提供者在协助患者做出临床试验决策方面所扮演角色的平均信念得分,在培训后立即从4.1提高至4.6(1-5分量表;p < .001)。这一改善在3个月随访时维持在4.5分(p < .001)。此外,愿意就临床试验进行沟通的平均得分在培训后立即从4.3提高至4.6(1-5分量表;p < .001)。这一改善在3个月随访时维持在4.5分(p < .001)。行为指标在3个月随访时显著提高。研究人员询问提供者,在做出转诊前,其对多大比例的患者进行了有关接受癌症临床试验治疗的教育并鼓励他们咨询接受癌症临床试验治疗的相关事宜。教育(15.1%至52.9%)和鼓励咨询(17.6%至62.4%)均有所提高(p < 0.001)。研究人员就那些在肿瘤科就诊后返回讨论治疗方案的患者向提供者提出了相同的问题。教育(13.9%至49.5%)和鼓励咨询(20.7%至47.8%)均显著提高(p < 0.001)。 知识、态度、信念、沟通和转诊行为的显著改善表明该在线课程是有效的。未来的推广和可持续性计划包括将该在线课程整合到医学和护理教育课程中。
查看英文原文 English abstract
We examined the impact of an online training intervention, “Preparing Patients for Cancer Treatment Discussions,” on primary care providers' knowledge, attitudes/beliefs, and communication/referral behavior. We partnered with Clinical Directors Network (CDN), Florida Academy of Family Physicians, and U.S. Residency Program Directors to recruit primary care providers (MDs, DOs, NPs, and PAs), Family Medicine residents, Internal Medicine residents and Geriatric fellows. The 1-hour, asynchronous online training was hosted by three faculty members: a primary care provider, radiation oncologist, and cancer clinical trials expert. Participants engaged in simulated patient and clinical scenarios to practice communication about oncology referrals and cancer clinical trials. Pre- and post-training surveys measured knowledge, attitudes, beliefs, and willingness to discuss trials. Further, a 3-month follow-up survey measured the sustained impact of the training on communication behavior about clinical trial referrals. 135 primary care providers (91 residents, 44 practicing clinicians) participated in the training intervention (84% retention at 3-month follow-up). Knowledge improved from a mean of 51.8% to 82.4% correct ( p <.001) immediately after training and was sustained with a mean score of 77.7% correct ( p <.001) at 3-month follow-up. Mean belief scores concerning the primary care provider's role in assisting patients with decisions about clinical trials increased from 4.1 to 4.6 (1-5 scale; p<.001) immediately following training. This improvement was sustained at a score of 4.5 (p<.001) during the 3-month follow-up. Additionally, mean scores for the willingness to communicate about clinical trials increased from 4.3 to 4.6 (1-5 scale; p<.001) immediately after training. This improvement was sustained at a score 4.5 (p<.001) during the 3-month follow-up. Behavior measures increased significantly at 3-month follow-up. Providers were asked the percentage of patients they educated about receiving treatment with a cancer clinical trial and encouraged to inquire about receiving treatment from a cancer clinical trial prior to making a referral. Education (15.1% to 52.9%) and inquiry encouragement (17.6% to 62.4%) both increased ( p <0.001). Providers were asked the same questions regarding patients that returned after their oncology visit to discuss treatment options. Education (13.9% to 49.5%) and inquiry encouragement (20.7% to 47.8%) both increased significantly ( p <0.001). Significant improvements in knowledge, attitudes, beliefs, communication and referral behavior demonstrate the online course was effective. Future plans for dissemination and sustainability include integrating the online course into curricula for medical and nursing education.
利益披露 Disclosure
C. Bylund, None.. A. Crowe, None.. M. Michaels, None.. D. Durante, None.. M. Sae-Hau, None. A. Cassells, Bristol Myers Squibb ). Johnson & Johnson/Janssen ). Blood Cancer United ). Syneos Health ). Campbell Foundation ). American Diabetes Association/CVS Health Foundation ). Wellcome Leap ). Stavros Niarchos Foundation for Global Infectious Disease Research ). VisonHealth ). J. Arnold, None.. A. Natale-Pereira, None.. R. Mailhot Vega, None.. Z. Zhang, None.. J. Lee, None.. E. S. Weiss, None.

← 返回 AACR 2026 检索